|
시장보고서
상품코드
1571366
구독해야 할 사람은 누구인가? 시장 규모 및 예측 - 세계 및 지역별 점유율, 동향, 성장 기회 분석 : 질환별, 서비스 제공업체별, 지역별 분석Medical Second Opinion Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Condition, Service Providers, and Geography |
||||||
구독해야 할 사람은 누구인가? 시장은 2023년 53억 3,000만 달러에서 2031년 154억 달러에 달할 것으로 예상되며, 2023-2031년 연평균 14.2%의 성장률을 보일 것으로 예측됩니다. 의료 2차 진료 시장의 성장은 더 나은 치료 결과를 중시하는 경향과 의료 비용 최적화에 대한 선호도가 높아지면서 의료 2차 진료 시장의 성장에 기인합니다.
의료 세컨드오피니언은 환자가 진단받은 사례, 치료법, 질환에 대해 다른 의료 서비스 제공업체에게 전문적인 평가나 평가를 요청하는 과정입니다. 이를 통해 환자는 진단을 확인하고, 대체 치료 옵션을 찾고, 자신의 건강에 대한 결정에 대해 안심할 수 있습니다. 특히 심각한 증상이나 복잡한 의료 사례, 또는 환자가 처음 받은 권고에 대해 불안감을 느끼는 경우, 두 번째 의견을 구하는 것이 특히 중요합니다. 두 번째 의견을 얻는 것은 환자에게 더 많은 정보를 제공하고 건강 상태에 대한 관점을 제공함으로써 환자에게 힘을 실어줄 수 있습니다.
2023년 세계 의료 2차 진료 시장에서 북미가 큰 비중을 차지할 것으로 예상됩니다. 북미 구독해야 할 사람은 누구인가? 시장은 미국, 캐나다, 멕시코로 구분됩니다. 소아 인구의 호흡기 질환 사례 증가와 의료기기에 대한 투자 증가는 예측 기간 동안 북미 구독해야 할 사람은 누구인가? 시장의 성장을 가속화할 것으로 예상되는 몇 가지 요인 중 하나입니다.
북미에서는 미국이 의료 2차 소견 시장에서 가장 큰 점유율을 차지하고 있습니다. 미국 시장의 성장은 주로 암 유병률 증가에 의해 주도되고 있습니다. 암은 미국 내 사망 원인 중 2위를 차지하고 있습니다. 미국 암협회에 따르면 2022년 미국에서 190만 명 이상이 새로 암 진단을 받고 약 609,360명이 사망할 것으로 예상하고 있습니다. 또한, 2024년에는 미국에서 200만 명 이상이 암 진단을 받을 것으로 예상됩니다. 암 오진 사례 증가와 그 악영향으로 인해 의료 2차 소견에 대한 수요가 증가하고 있습니다.
존스홉킨스대학의 조사에 따르면 미국에서는 매년 4,000건의 수술 실수가 발생합니다. 또한 '사망으로 이어지는 10 대 의료 과실'이라는 조사에 따르면 미국에서 매년 7,000 - 9,000 명의 환자가 투약 실수로 사망하고 있으며, 2023년 7 월에 발표된 논문 "Burden of serious harms from diagnostic error in the USA"에 따르면, 매년 약 795,000명의 미국인이 심각한 질병의 오진으로 인해 고통받고 있습니다. 이러한 의료 과오가 많아질수록 국가의 의료 2차 소견에 대한 필요성이 급증할 것으로 예상됩니다.
2017년 UnitedHealthcare는 2nd.MD와 협력하여 회원을 위한 전문가 의료 의견 서비스를 무료로 제공했으며, 2nd.MD는 의료 의견 서비스 분야의 전문가와 가상으로 연결하여 사례를 검토하고 2차 의견을 제공합니다. 또한 치료 계획 검토, 진단 확인, 문의에 대한 답변, 신속한 2차 의견 제공을 위해 의사와 환자를 연결하여 환자를 지원하는 조직도 있습니다. 예를 들어, 월드케어 인터내셔널(WorldCare International)은 전 세계 보험 가입자들에게 심각한 질병에 대한 구독해야 할 사람은 누구인가?의 표준을 제공합니다. 이 서비스는 암, 심혈관 질환, 신경 질환, 근골격계 질환, 혈액 질환 등 100가지 이상의 중증 질환을 다루고 있습니다.
의료 컨설팅 서비스의 디지털화가 향후 시장 기회를 가져다 줄 것
의료 서비스와 디지털 플랫폼의 통합이 진행됨에 따라 디지털 진료의 인기와 수용성이 높아지고 있습니다. 디지털 플랫폼을 통해 환자들은 병원이나 진료소를 방문하지 않고도 2차 의료 의견을 얻을 수 있습니다. 이 서비스는 환자의 편의성, 환자 경험 개선, 효과적인 비용 관리를 가능하게 합니다. 디지털 플랫폼을 도입함으로써 환자들은 원격지에서도 의료 전문가에게 쉽게 접근하여 진료를 받을 수 있습니다. 소프트웨어 개발 기업과 의료 기관 간의 협업과 파트너십이 증가하면서 의료 컨설팅 서비스의 디지털화가 가속화되고 있습니다. 예를 들어, 2021년 10월 NorthShore University HealthSystem은 타이토케어(TytoCare)와 파트너십을 맺고 의료진이 원격 의료를 통해 환자를 진단하고 치료할 수 있도록 했습니다. 노스쇼어는 시카고 지역 주민들에게 서비스를 제공하고 6개의 병원을 운영하고 있으며, 2021년 10월 시그나헬스플랜(Signa Health Plan)은 디지털 우선의 1차 진료, 피부과, 행동 치료, 응급 치료 등 대상 가상 진료 서비스에 대한 접근성을 대폭 확대할 것이라고 발표했습니다. 발표했습니다. 의료 컨설팅 서비스의 디지털화 진전은 향후 몇 년동안 의료 2차 진료 시장의 성장에 기여할 것으로 예상됩니다.
의료 2차 소견 시장 경쟁 정세와 주요 발전
Medisense Healthcare Solutions Pvt. Ltd., Second Opinion International, Elite Medical Services, The Cigna Group, Helsana, WorldCare, Vidal Health Insurance TPA Pvt Ltd, Medix, 2nd.MD, Axa SA, Teladoc Health Inc, DoctorSpring Pvt. Clinic, Included Health, Inc.(Partners Healthcare), Stanford Health Care, Royal Doctors 등이 의료 2차 소견 시장에서 사업을 전개하는 주요 기업들입니다.
미국 식품의약국, American College of Allergy Asthma and Immunology, The Barcelona Institute for Global Health, Our World in data 등은 의료 2차 소견 시장 보고서 작성 참고한 1차 정보 및 2차 정보입니다.
목차
제1장 서론
제2장 주요 요약
- 주요 인사이트
제3장 조사 방법
- 2차 조사
- 1차 조사
- 가설 책정
- 거시경제 요인 분석
- 기초 수치 작성
- 데이터 삼각측량
- 국가 레벨 데이터
제4장 의료 2차 소견 시장 구도
- PEST 분석
제5장 의료 2차 소견 시장 : 주요 시장 역학
- 의료 2차 소견 시장-주요 시장 역학
- 시장 성장 촉진요인
- 시장 성장 억제요인
- 시장 기회
- 향후 동향
- 성장 촉진요인과 억제요인의 영향
제6장 의료 2차 소견 시장 : 세계 시장 분석
- 의료 2차 소견 시장 매출, 2021년-2031년
- 의료 2차 소견 시장 예측 분석
제7장 의료 2차 소견 시장 분석 - 질환별
- 암
- 정형외과 질환
- 심장 질환
- 신경 질환
- 신장 질환
- 혈액 질환
- 만성 폐쇄성 폐질환(COPD)
- 장기 이식
- 기타
제8장 의료 2차 소견 시장 분석 - 서비스 제공업체별
- 병원
- 건강보험사
- 온라인 서비스
제9장 의료 2차 소견 시장 분석 - 지역별
- 북미
- 미국
- 캐나다
- 멕시코
- 유럽
- 독일
- 영국
- 프랑스
- 이탈리아
- 스페인
- 기타 유럽
- 아시아태평양
- 중국
- 일본
- 인도
- 호주
- 한국
- 기타 아시아태평양
- 중동 및 아프리카
- 사우디아라비아
- 남아프리카공화국
- 아랍에미리트(UAE)
- 기타 중동 및 아프리카
- 중남미
- 브라질
- 아르헨티나
- 기타 중남미
제10장 업계 상황
- 의료 2차 소견 시장 성장 전략
- 유기적 성장 전략
- 무기적 성장 전략
- 성장 전략
제11장 기업 개요
- Second Opinion International
- Elite Medical Services
- The Cigna Group
- Helsana
- WorldCare
- Vidal Health Insurance TPA Pvt Ltd
- 2nd.MD
- Axa SA
- Teladoc Health Inc
- Included Health, Inc.
- Royal Doctors
제12장 부록
LSH 24.10.28According to our new research study on "Medical Second Opinion Market Forecast to 2031 -Global Analysis - by Condition, Service Providers, Geography," the market is anticipated to grow from US$ 5.33 billion in 2023 and is projected to reach US$ 15.40 billion by 2031; it is expected to register a CAGR of 14.2% during 2023-2031. The medical second opinion market growth is attributed to the growing emphasis on better treatment outcomes and an increasing preference for healthcare cost optimization.
A medical second opinion is the process through which a patient seeks another professional assessment or evaluation of a diagnosed case, a treatment, or a medical condition by a different provider. This helps patients confirm a diagnosis, seek alternative treatment options, and be reassured about the decisions they make with respect to their health. Getting a second opinion is especially true for serious conditions, complex medical cases, and the uncertainty of a patient in relation to the first recommendation they received. This is apt to empower patients by giving them more information as well as perspectives on their health status.
North America accounted for a major share of the global medical second opinion market in 2023. The North America medical second opinion market is segmented into the US, Canada, and Mexico. Increasing cases of respiratory diseases in the pediatric population and growing investments in medical devices are among a few factors that are projected to accelerate the growth of the medical second opinions market in North America during the forecast period.
In North America, the US holds a significant share of the medical second opinions market. The growth of the market in the country is primarily driven by the increasing prevalence of cancer. Cancer is the second leading cause of death in the country. According to the American Cancer Society, in 2022, more than 1.9 million new cases of cancer were diagnosed in the nation, causing about 609,360 deaths. Further, ~2.0 million people are expected to be diagnosed with cancer in the US in 2024. The increasing number of misdiagnosed cancer cases and its adverse effects are propelling the demand for medical second opinions.
According to research from Johns Hopkins University., ~4,000 surgical errors are caused every year in the US. Further, according to a study, "Top 10 Medical Errors That Lead to Death," ~7,000 to 9,000 patients die due to medication errors each year in the US. According to the article "Burden of serious harms from diagnostic error in the USA," published in July 2023, about 795,000 Americans suffer due to misdiagnosis of serious diseases each year. Such a high number of medical errors is anticipated to surge the country's need for medical second opinion.
In 2017, UnitedHealthcare collaborated with 2nd.MD to provide members with a no-cost, member-focused expert medical opinion service. 2nd.MD virtually connects to a medical opinion service field specialist to review cases and provide a second opinion. In addition, several organizations assist patients by linking them to doctors for reviewing treatment plans, confirming diagnoses, responding to inquiries, and providing rapid second opinions. For instance, WorldCare International Inc. offers the gold standard of medical second opinions for critical illnesses to covered members worldwide. The service covers more than 100 categories of critical illness, including cancer, cardiovascular diseases, neurological disorders, musculoskeletal disorders, and hematology conditions.
Digitalization of Medical Consulting Services to Provide Market Opportunities in Future
The increasing integration of medical services and digital platforms is causing increased popularity and acceptance of digital consultation. This digital platform allows patients to get a second medical opinion without any visit to the hospitals or clinics. The service can provide significant patient convenience, improved patient experience, and effective cost management. Deploying digital platforms enables patients to be consulted from any remote region with better accessibility to medical experts. The increase in collaborations and partnerships between software development companies and healthcare institutions is accelerating the digitalization of medical consulting services. For instance, in October 2021, NorthShore University HealthSystem partnered with TytoCare to help providers diagnose and treat patients using telehealth. NorthShore serves residents across the Chicago metropolitan area and operates six hospitals. In October 2021, Cigna Health Plan announced that it was significantly expanding access to covered virtual care services, including digital-first primary, dermatology, behavioral and urgent care. The growing digitalization of medical consulting services is expected to contribute to the growth of the medical second opinion market in the coming years.
Medical Second Opinion Market: Competitive Landscape and Key Developments
Medisense Healthcare Solutions Pvt. Ltd.; Second Opinion International; Elite Medical Services; The Cigna Group; Helsana; WorldCare; Vidal Health Insurance TPA Pvt Ltd; Medix; 2nd.MD; Axa SA; Teladoc Health Inc; DoctorSpring Pvt. Ltd; USARAD Holdings Inc (SecondOpinions.com); Cleveland Clinic; Included Health, Inc.; Mass General Brigham Incorporated. (Partners Healthcare); Stanford Health Care; and Royal Doctors are among the key companies operating in the medical second opinion market.
The US Food and Drug Administration, American College of Allergy Asthma and Immunology, The Barcelona Institute for Global Health, and Our World in data are among the primary and secondary sources referred to while preparing the medical second opinion market report.
Table Of Contents
1. Introduction
- 1.1 The Insight Partners Research Report Guidance
- 1.2 Market Segmentation
2. Executive Summary
- 2.1 Key Insights
3. Research Methodology
- 3.1 Secondary Research
- 3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
4. Medical Second Opinion Market Landscape
- 4.1 Overview
- 4.2 PEST Analysis
5. Medical Second Opinion Market - Key Market Dynamics
- 5.1 Medical Second Opinion Market - Key Market Dynamics
- 5.2 Market Drivers
- 5.2.1 Growing Emphasis on Better Treatment Outcomes
- 5.2.2 Increasing Preference for Healthcare Cost Optimization
- 5.3 Market Restraints
- 5.3.1 Lack of Awareness and Reluctance Toward Adoption of Medical Second Opinion in Emerging Nations
- 5.4 Market Opportunities
- 5.4.1 Rising Collaborations in Telemedicine Technologies
- 5.5 Future Trends
- 5.5.1 Digitalization of Medical Consulting Services
- 5.6 Impact of Drivers and Restraints:
6. Medical Second Opinion Market - Global Market Analysis
- 6.1 Medical Second Opinion Market Revenue (US$ Million), 2021-2031
- 6.2 Medical Second Opinion Market Forecast Analysis
7. Medical Second Opinion Market Analysis - by Condition
- 7.1 Cancer
- 7.1.1 Overview
- 7.1.2 Cancer: Medical Second Opinion Market - Revenue and Forecast to 2031 (US$ Million)
- 7.2 Orthopedic Disorders
- 7.2.1 Overview
- 7.2.2 Orthopedic Disorders: Medical Second Opinion Market - Revenue and Forecast to 2031 (US$ Million)
- 7.3 Cardiac Disorders
- 7.3.1 Overview
- 7.3.2 Cardiac Disorders: Medical Second Opinion Market - Revenue and Forecast to 2031 (US$ Million)
- 7.4 Neurological Disorders
- 7.4.1 Overview
- 7.4.2 Neurological Disorders: Medical Second Opinion Market - Revenue and Forecast to 2031 (US$ Million)
- 7.5 Nephrological Disorders
- 7.5.1 Overview
- 7.5.2 Nephrological Disorders: Medical Second Opinion Market - Revenue and Forecast to 2031 (US$ Million)
- 7.6 Hematological Blood Disorders
- 7.6.1 Overview
- 7.6.2 Hematological Blood Disorders: Medical Second Opinion Market - Revenue and Forecast to 2031 (US$ Million)
- 7.7 COPD
- 7.7.1 Overview
- 7.7.2 COPD: Medical Second Opinion Market - Revenue and Forecast to 2031 (US$ Million)
- 7.8 Organ Transplant
- 7.8.1 Overview
- 7.8.2 Organ Transplant: Medical Second Opinion Market - Revenue and Forecast to 2031 (US$ Million)
- 7.9 Others
- 7.9.1 Overview
- 7.9.2 Others: Medical Second Opinion Market - Revenue and Forecast to 2031 (US$ Million)
8. Medical Second Opinion Market Analysis - by Service Provider
- 8.1 Hospitals
- 8.1.1 Overview
- 8.1.2 Hospitals: Medical Second Opinion Market - Revenue and Forecast to 2031 (US$ Million)
- 8.2 Health Insurance Companies
- 8.2.1 Overview
- 8.2.2 Health Insurance Companies: Medical Second Opinion Market - Revenue and Forecast to 2031 (US$ Million)
- 8.3 Online Services
- 8.3.1 Overview
- 8.3.2 Online Services: Medical Second Opinion Market - Revenue and Forecast to 2031 (US$ Million)
9. Medical Second Opinion Market - Geographical Analysis
- 9.1 North America
- 9.1.1 North America Medical Second Opinion Market Overview
- 9.1.2 North America: Medical Second Opinion Market - Revenue and Forecast to 2031 (US$ Million)
- 9.1.2.1 North America: Medical Second Opinion Market - Revenue and Forecast Analysis - by Condition
- 9.1.2.2 North America: Medical Second Opinion Market - Revenue and Forecast Analysis - by Service Provider
- 9.1.3 North America: Medical Second Opinion Market - Revenue and Forecast Analysis - by Country
- 9.1.3.1 United States: Medical Second Opinion Market - Revenue and Forecast to 2031 (US$ Million)
- 9.1.3.1.1 United States: Medical Second Opinion Market Breakdown, by Condition
- 9.1.3.1.2 United States: Medical Second Opinion Market Breakdown, by Service Provider
- 9.1.3.2 Canada: Medical Second Opinion Market - Revenue and Forecast to 2031 (US$ Million)
- 9.1.3.2.1 Canada: Medical Second Opinion Market Breakdown, by Condition
- 9.1.3.2.2 Canada: Medical Second Opinion Market Breakdown, by Service Provider
- 9.1.3.3 Mexico: Medical Second Opinion Market - Revenue and Forecast to 2031 (US$ Million)
- 9.1.3.3.1 Mexico: Medical Second Opinion Market Breakdown, by Condition
- 9.1.3.3.2 Mexico: Medical Second Opinion Market Breakdown, by Service Provider
- 9.1.3.1 United States: Medical Second Opinion Market - Revenue and Forecast to 2031 (US$ Million)
- 9.2 Europe
- 9.2.1 Europe Medical Second Opinion Market Overview
- 9.2.2 Europe: Medical Second Opinion Market - Revenue and Forecast to 2031 (US$ Million)
- 9.2.2.1 Europe: Medical Second Opinion Market - Revenue and Forecast Analysis - by Condition
- 9.2.2.2 Europe: Medical Second Opinion Market - Revenue and Forecast Analysis - by Service Provider
- 9.2.3 Europe: Medical Second Opinion Market - Revenue and Forecast Analysis - by Country
- 9.2.3.1 Germany: Medical Second Opinion Market - Revenue and Forecast to 2031 (US$ Million)
- 9.2.3.1.1 Germany: Medical Second Opinion Market Breakdown, by Condition
- 9.2.3.1.2 Germany: Medical Second Opinion Market Breakdown, by Service Provider
- 9.2.3.2 United Kingdom: Medical Second Opinion Market - Revenue and Forecast to 2031 (US$ Million)
- 9.2.3.2.1 United Kingdom: Medical Second Opinion Market Breakdown, by Condition
- 9.2.3.2.2 United Kingdom: Medical Second Opinion Market Breakdown, by Service Provider
- 9.2.3.3 France: Medical Second Opinion Market - Revenue and Forecast to 2031 (US$ Million)
- 9.2.3.3.1 France: Medical Second Opinion Market Breakdown, by Condition
- 9.2.3.3.2 France: Medical Second Opinion Market Breakdown, by Service Provider
- 9.2.3.4 Italy: Medical Second Opinion Market - Revenue and Forecast to 2031 (US$ Million)
- 9.2.3.4.1 Italy: Medical Second Opinion Market Breakdown, by Condition
- 9.2.3.4.2 Italy: Medical Second Opinion Market Breakdown, by Service Provider
- 9.2.3.5 Spain: Medical Second Opinion Market - Revenue and Forecast to 2031 (US$ Million)
- 9.2.3.5.1 Spain: Medical Second Opinion Market Breakdown, by Condition
- 9.2.3.5.2 Spain: Medical Second Opinion Market Breakdown, by Service Provider
- 9.2.3.6 Rest of Europe: Medical Second Opinion Market - Revenue and Forecast to 2031 (US$ Million)
- 9.2.3.6.1 Rest of Europe: Medical Second Opinion Market Breakdown, by Condition
- 9.2.3.6.2 Rest of Europe: Medical Second Opinion Market Breakdown, by Service Provider
- 9.2.3.1 Germany: Medical Second Opinion Market - Revenue and Forecast to 2031 (US$ Million)
- 9.3 Asia Pacific
- 9.3.1 Asia Pacific Medical Second Opinion Market Overview
- 9.3.2 Asia Pacific: Medical Second Opinion Market - Revenue and Forecast to 2031 (US$ Million)
- 9.3.2.1 Asia Pacific: Medical Second Opinion Market - Revenue and Forecast Analysis - by Condition
- 9.3.2.2 Asia Pacific: Medical Second Opinion Market - Revenue and Forecast Analysis - by Service Provider
- 9.3.3 Asia Pacific: Medical Second Opinion Market - Revenue and Forecast Analysis - by Country
- 9.3.3.1 China: Medical Second Opinion Market - Revenue and Forecast to 2031 (US$ Million)
- 9.3.3.1.1 China: Medical Second Opinion Market Breakdown, by Condition
- 9.3.3.1.2 China: Medical Second Opinion Market Breakdown, by Service Provider
- 9.3.3.2 Japan: Medical Second Opinion Market - Revenue and Forecast to 2031 (US$ Million)
- 9.3.3.2.1 Japan: Medical Second Opinion Market Breakdown, by Condition
- 9.3.3.2.2 Japan: Medical Second Opinion Market Breakdown, by Service Provider
- 9.3.3.3 India: Medical Second Opinion Market - Revenue and Forecast to 2031 (US$ Million)
- 9.3.3.3.1 India: Medical Second Opinion Market Breakdown, by Condition
- 9.3.3.3.2 India: Medical Second Opinion Market Breakdown, by Service Provider
- 9.3.3.4 Australia: Medical Second Opinion Market - Revenue and Forecast to 2031 (US$ Million)
- 9.3.3.4.1 Australia: Medical Second Opinion Market Breakdown, by Condition
- 9.3.3.4.2 Australia: Medical Second Opinion Market Breakdown, by Service Provider
- 9.3.3.5 South Korea: Medical Second Opinion Market - Revenue and Forecast to 2031 (US$ Million)
- 9.3.3.5.1 South Korea: Medical Second Opinion Market Breakdown, by Condition
- 9.3.3.5.2 South Korea: Medical Second Opinion Market Breakdown, by Service Provider
- 9.3.3.6 Rest of APAC: Medical Second Opinion Market - Revenue and Forecast to 2031 (US$ Million)
- 9.3.3.6.1 Rest of APAC: Medical Second Opinion Market Breakdown, by Condition
- 9.3.3.6.2 Rest of APAC: Medical Second Opinion Market Breakdown, by Service Provider
- 9.3.3.1 China: Medical Second Opinion Market - Revenue and Forecast to 2031 (US$ Million)
- 9.4 Middle East & Africa
- 9.4.1 Middle East & Africa Medical Second Opinion Market Overview
- 9.4.2 Middle East & Africa: Medical Second Opinion Market - Revenue and Forecast to 2031 (US$ Million)
- 9.4.2.1 Middle East & Africa: Medical Second Opinion Market - Revenue and Forecast Analysis - by Condition
- 9.4.2.2 Middle East & Africa: Medical Second Opinion Market - Revenue and Forecast Analysis - by Service Provider
- 9.4.3 Middle East & Africa: Medical Second Opinion Market - Revenue and Forecast Analysis - by Country
- 9.4.3.1 Saudi Arabia: Medical Second Opinion Market - Revenue and Forecast to 2031 (US$ Million)
- 9.4.3.1.1 Saudi Arabia: Medical Second Opinion Market Breakdown, by Condition
- 9.4.3.1.2 Saudi Arabia: Medical Second Opinion Market Breakdown, by Service Provider
- 9.4.3.2 South Africa: Medical Second Opinion Market - Revenue and Forecast to 2031 (US$ Million)
- 9.4.3.2.1 South Africa: Medical Second Opinion Market Breakdown, by Condition
- 9.4.3.2.2 South Africa: Medical Second Opinion Market Breakdown, by Service Provider
- 9.4.3.3 United Arab Emirates: Medical Second Opinion Market - Revenue and Forecast to 2031 (US$ Million)
- 9.4.3.3.1 United Arab Emirates: Medical Second Opinion Market Breakdown, by Condition
- 9.4.3.3.2 United Arab Emirates: Medical Second Opinion Market Breakdown, by Service Provider
- 9.4.3.4 Rest of Middle East & Africa: Medical Second Opinion Market - Revenue and Forecast to 2031 (US$ Million)
- 9.4.3.4.1 Rest of Middle East & Africa: Medical Second Opinion Market Breakdown, by Condition
- 9.4.3.4.2 Rest of Middle East & Africa: Medical Second Opinion Market Breakdown, by Service Provider
- 9.4.3.1 Saudi Arabia: Medical Second Opinion Market - Revenue and Forecast to 2031 (US$ Million)
- 9.5 South & Central America
- 9.5.1 South & Central America Medical Second Opinion Market Overview
- 9.5.2 South & Central America: Medical Second Opinion Market - Revenue and Forecast to 2031 (US$ Million)
- 9.5.2.1 South & Central America: Medical Second Opinion Market - Revenue and Forecast Analysis - by Condition
- 9.5.2.2 South & Central America: Medical Second Opinion Market - Revenue and Forecast Analysis - by Service Provider
- 9.5.3 South & Central America: Medical Second Opinion Market - Revenue and Forecast Analysis - by Country
- 9.5.3.1 Brazil: Medical Second Opinion Market - Revenue and Forecast to 2031 (US$ Million)
- 9.5.3.1.1 Brazil: Medical Second Opinion Market Breakdown, by Condition
- 9.5.3.1.2 Brazil: Medical Second Opinion Market Breakdown, by Service Provider
- 9.5.3.2 Argentina: Medical Second Opinion Market - Revenue and Forecast to 2031 (US$ Million)
- 9.5.3.2.1 Argentina: Medical Second Opinion Market Breakdown, by Condition
- 9.5.3.2.2 Argentina: Medical Second Opinion Market Breakdown, by Service Provider
- 9.5.3.3 Rest of South & Central America: Medical Second Opinion Market - Revenue and Forecast to 2031 (US$ Million)
- 9.5.3.3.1 Rest of South & Central America: Medical Second Opinion Market Breakdown, by Condition
- 9.5.3.3.2 Rest of South & Central America: Medical Second Opinion Market Breakdown, by Service Provider
- 9.5.3.1 Brazil: Medical Second Opinion Market - Revenue and Forecast to 2031 (US$ Million)
10. Industry Landscape
- 10.1 Overview
- 10.2 Growth Strategies in Medical Second Opinion Market
- 10.3 Organic Growth Strategies
- 10.3.1 Overview
- 10.4 Inorganic Growth Strategies
- 10.4.1 Overview
11. Company Profiles
- 11.1 Second Opinion International
- 11.1.1 Key Facts
- 11.1.2 Business Description
- 11.1.3 Products and Services
- 11.1.4 Financial Overview
- 11.1.5 SWOT Analysis
- 11.1.6 Key Developments
- 11.2 Elite Medical Services
- 11.2.1 Key Facts
- 11.2.2 Business Description
- 11.2.3 Products and Services
- 11.2.4 Financial Overview
- 11.2.5 SWOT Analysis
- 11.2.6 Key Developments
- 11.3 The Cigna Group
- 11.3.1 Key Facts
- 11.3.2 Business Description
- 11.3.3 Products and Services
- 11.3.4 Financial Overview
- 11.3.5 SWOT Analysis
- 11.3.6 Key Developments
- 11.4 Helsana
- 11.4.1 Key Facts
- 11.4.2 Business Description
- 11.4.3 Products and Services
- 11.4.4 Financial Overview
- 11.4.5 SWOT Analysis
- 11.4.6 Key Developments
- 11.5 WorldCare
- 11.5.1 Key Facts
- 11.5.2 Business Description
- 11.5.3 Products and Services
- 11.5.4 Financial Overview
- 11.5.5 SWOT Analysis
- 11.5.6 Key Developments
- 11.6 Vidal Health Insurance TPA Pvt Ltd
- 11.6.1 Key Facts
- 11.6.2 Business Description
- 11.6.3 Products and Services
- 11.6.4 Financial Overview
- 11.6.5 SWOT Analysis
- 11.6.6 Key Developments
- 11.7 2nd.MD
- 11.7.1 Key Facts
- 11.7.2 Business Description
- 11.7.3 Products and Services
- 11.7.4 Financial Overview
- 11.7.5 SWOT Analysis
- 11.7.6 Key Developments
- 11.8 Axa SA
- 11.8.1 Key Facts
- 11.8.2 Business Description
- 11.8.3 Products and Services
- 11.8.4 Financial Overview
- 11.8.5 SWOT Analysis
- 11.8.6 Key Developments
- 11.9 Teladoc Health Inc
- 11.9.1 Key Facts
- 11.9.2 Business Description
- 11.9.3 Products and Services
- 11.9.4 Financial Overview
- 11.9.5 SWOT Analysis
- 11.9.6 Key Developments
- 11.10 Included Health, Inc.
- 11.10.1 Key Facts
- 11.10.2 Business Description
- 11.10.3 Products and Services
- 11.10.4 Financial Overview
- 11.10.5 SWOT Analysis
- 11.10.6 Key Developments
- 11.11 Royal Doctors
- 11.11.1 Key Facts
- 11.11.2 Business Description
- 11.11.3 Products and Services
- 11.11.4 Financial Overview
- 11.11.5 SWOT Analysis
- 11.11.6 Key Developments
12. Appendix
- 12.1 About The Insight Partners
- 12.2 Glossary of Terms
